Inflammation and immune mechanisms are crucially involved in the pathophysiology of the
development, acute damage cascades, and chronic course after ischemic stroke …

Infection with the SARS-CoV-2 virus, resulting in COVID-19 disease, has presented a
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …

The underlying mechanisms by which severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) leads to acute and long-term neurological manifestations remains obscure …

Introduction COVID-19 might affect the incidence of specific neurological diseases, but it is
unknown if this differs from the risk following other infections. Here, we characterized the …

Cerebral small vessel disease (CSVD) is the leading cause of vascular cognitive impairment
and is associated with COVID-19. However, contributing factors that often accompany CSVD …

Introduction One of the rare but potentially serious side effects of COVID-19 vaccination is
arterial and venous thrombosis. Acute ischemic stroke (AIS) cases have been reported post …

Introduction In addition to the deleterious effects Covid-19 has on the pulmonary and
cardiovascular systems, COVID-19 can also result in damage to the nervous system. This …

Background and Objectives Acute arterial ischemic stroke (AIS) has been reported as a rare
adverse event following coronavirus disease 2019 (COVID-19) vaccination with messenger …

SARS-CoV-2, the virus underlying COVID-19, has now been recognized to cause
multiorgan disease with a systemic effect on the host. To effectively combat SARS-CoV-2 …

Background: Cerebral venous sinus or vein thromboses (SVT) are treated with heparin
followed by oral anticoagulation. Even after receiving the best medical treatment, numerous …